Correlation Between Sealed Air and Tscan Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Sealed Air and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sealed Air and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sealed Air and Tscan Therapeutics, you can compare the effects of market volatilities on Sealed Air and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sealed Air with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sealed Air and Tscan Therapeutics.

Diversification Opportunities for Sealed Air and Tscan Therapeutics

-0.5
  Correlation Coefficient

Very good diversification

The 3 months correlation between Sealed and Tscan is -0.5. Overlapping area represents the amount of risk that can be diversified away by holding Sealed Air and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Sealed Air is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sealed Air are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Sealed Air i.e., Sealed Air and Tscan Therapeutics go up and down completely randomly.

Pair Corralation between Sealed Air and Tscan Therapeutics

Considering the 90-day investment horizon Sealed Air is expected to under-perform the Tscan Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Sealed Air is 3.42 times less risky than Tscan Therapeutics. The stock trades about -0.01 of its potential returns per unit of risk. The Tscan Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest  158.00  in Tscan Therapeutics on September 12, 2024 and sell it today you would earn a total of  175.00  from holding Tscan Therapeutics or generate 110.76% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Sealed Air  vs.  Tscan Therapeutics

 Performance 
       Timeline  
Sealed Air 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Sealed Air are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting technical and fundamental indicators, Sealed Air may actually be approaching a critical reversion point that can send shares even higher in January 2025.
Tscan Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Tscan Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Sealed Air and Tscan Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Sealed Air and Tscan Therapeutics

The main advantage of trading using opposite Sealed Air and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sealed Air position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.
The idea behind Sealed Air and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Share Portfolio
Track or share privately all of your investments from the convenience of any device
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Fundamental Analysis
View fundamental data based on most recent published financial statements